Relevant treatment-related variables considered for adjusted analysis
| Iodixanol | LOCMa | P Value | |
|---|---|---|---|
| Time to IV therapy (min) (median) | 124 | 115 | .25 |
| Onset to puncture (min) (median) | 215 | 205 | .29 |
| Proximal M1 (vs distal) (%) | 45.2 | 52.0 | .51 |
| Thrombolysis only (%) | 41.9 | 36.2 | .57 |
| No. microcatheter injections (median) | 1 | 2 | .03 |
| Heparin volume (U) (median) | 3185 | 2986.8 | .59 |
| New emboli (%) | 16.1 | 11.8 | .54 |
| IRCM volume (mL) (median) | 85 | 64 | .34 |
| Infarct volume 24 hr (mL)a (median) | 61.0 | 50.2 | .23 |
↵a Four LOCM (mOsm/Kg H2O): iohexol (672), iopamidol (616), ioversol (651), iopromide (607).11